GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (XBUL:SFA) » Definitions » Gross Margin %

Sopharma AD-Sofia (XBUL:SFA) Gross Margin % : 22.61% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Sopharma AD-Sofia Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Sopharma AD-Sofia's Gross Profit for the three months ended in Dec. 2023 was лв113 Mil. Sopharma AD-Sofia's Revenue for the three months ended in Dec. 2023 was лв500 Mil. Therefore, Sopharma AD-Sofia's Gross Margin % for the quarter that ended in Dec. 2023 was 22.61%.

Warning Sign:

Sopharma AD-Sofia gross margin has been in long-term decline. The average rate of decline per year is -1.4%.


The historical rank and industry rank for Sopharma AD-Sofia's Gross Margin % or its related term are showing as below:

XBUL:SFA' s Gross Margin % Range Over the Past 10 Years
Min: 21.11   Med: 23.12   Max: 26.4
Current: 21.65


During the past 13 years, the highest Gross Margin % of Sopharma AD-Sofia was 26.40%. The lowest was 21.11%. And the median was 23.12%.

XBUL:SFA's Gross Margin % is ranked better than
58.51% of 94 companies
in the Medical Distribution industry
Industry Median: 16.22 vs XBUL:SFA: 21.65

Sopharma AD-Sofia had a gross margin of 22.61% for the quarter that ended in Dec. 2023 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Sopharma AD-Sofia was -1.40% per year.


Sopharma AD-Sofia Gross Margin % Historical Data

The historical data trend for Sopharma AD-Sofia's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma AD-Sofia Gross Margin % Chart

Sopharma AD-Sofia Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.58 21.11 21.29 21.43 21.65

Sopharma AD-Sofia Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.46 22.05 22.96 18.92 22.61

Competitive Comparison of Sopharma AD-Sofia's Gross Margin %

For the Medical Distribution subindustry, Sopharma AD-Sofia's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma AD-Sofia's Gross Margin % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Sopharma AD-Sofia's Gross Margin % falls into.



Sopharma AD-Sofia Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Sopharma AD-Sofia's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=406 / 1875.304
=(Revenue - Cost of Goods Sold) / Revenue
=(1875.304 - 1469.271) / 1875.304
=21.65 %

Sopharma AD-Sofia's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=113.1 / 500.322
=(Revenue - Cost of Goods Sold) / Revenue
=(500.322 - 387.218) / 500.322
=22.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Sopharma AD-Sofia  (XBUL:SFA) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Sopharma AD-Sofia had a gross margin of 22.61% for the quarter that ended in Dec. 2023 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Sopharma AD-Sofia Gross Margin % Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sopharma AD-Sofia (XBUL:SFA) Business Description

Traded in Other Exchanges
Address
5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are organized based on the production of finished products which include Tablet dosage forms, Ampoule dosage forms, Medical products, Other forms, and Other revenue. Geographically company operates in Bulgaria and internationally.

Sopharma AD-Sofia (XBUL:SFA) Headlines

No Headlines